Hemoglobin A1c Level 9 0 Dm4
Oct 31 2018 UncategorizedAfter a median follow-up of 12. 5 months, mirvetuximab soravtansine did not lead to a significant difference over chemotherapy in the primary endpoint of pfs in either the itt population (hr, 0..